Month: May 2023

Lecanemab’s Promise for Alzheimer’s Disease Revealed in Meta-Analysis and Review!

Imagine you’re a curious detective, investigating the effects of a powerful new drug called lecanemab on patients with Alzheimer’s disease (AD). You gather all the evidence from randomized controlled trials and piece them together like a puzzle. The results? Lecanemab shows promise in stabilizing or slowing down cognitive decline in patients with early AD. It […]

Published on May 5, 2023

Validating CNTB for Alzheimer’s and Parkinson’s Cognitive Assessment

Imagine you are a chef who has created a new recipe that combines flavors from different cultures. You want to make sure that your dish tastes great to people from all backgrounds. That’s exactly what the researchers behind the Cross-Cultural Neuropsychological Test Battery (CNTB) did – they designed a test battery to reduce cultural bias […]

Published on May 5, 2023

Age and balance: How the brain copes with standing

Imagine you’re trying to balance on a moving subway train. Your brain is working hard to keep your body stable and prevent you from falling. Now, imagine doing the same thing when you’re older. As we age, our ability to maintain balance becomes more challenging, leading to an increased risk of falls. In this study, […]

Published on May 5, 2023